Body mass index changes after the initiations of sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: LIN, Yi-Han (Chang Gung Memorial Hospital, Keelung, Taiwan, Department of Pharmacy, Keelung city, China Taiwan)
  • Co-author(s): Yung-Chi Lin:
    Shih-Chieh Shao: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan,
    Yuk-Ying Chan: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan,
  • Abstract:

    Methods

    We conducted the retrospective cohort study from May to December 2016 in one regional hospital in Taiwan. We identified adult patients with T2DM who initiated SGLT2i including empagliflozin and dapagliflozin and defined the first prescription date of SGLT2i as the index date. To better understand the baseline profiles, we excluded patients..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login